SequelSEC

Incannex Healthcare Inc. IXHL

Pharmaceutical Preparations · CIK 0001873875 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
$86.00K
Fiscal year ended 2025-06-30
Operating income
-$23.79M
Fiscal year ended 2025-06-30
Free cash flow
Unavailable
Fiscal year ended 2025-06-30

Valuation, from the filing

Public float$29.10MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-12-31
Float per share$0.08Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue338.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.2×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-06-30 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth-100.0%93th
Current ratio48.81x40th

Incannex Healthcare Inc. (IXHL) reported revenue of $86.00K and net income of -$46.88M for the fiscal year ended 2025-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Incannex Healthcare Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Incannex Healthcare Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Revenue$86.00K
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$23.79M
Net income-$46.88M
Research & development$10.75M
Weighted-average diluted sharesUnavailable
Pretax income-$46.88M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$13.13M
Selling & marketingUnavailable

Balance

Incannex Healthcare Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Cash & equivalents$15.04M
Total assets$20.45M
Current assets$19.96M
Total liabilities$7.06M
Current liabilities$6.98M
Total equity incl. NCI$13.39M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Incannex Healthcare Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Operating cash flow-$12.51M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$21.40M
Net change in cashUnavailable
Stock-based compensation$2.61M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$246.00K

Derived

Incannex Healthcare Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin-27661.6%
FCF marginUnavailable
SBC / revenue3033.7%
Current ratio2.86x
Revenue YoY growthUnavailable
Net margin-54517.4%
R&D / revenue12496.5%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IXHL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-09-25View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-Q · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-K · Filed 2025-09-29View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.